RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Aripiprazole for the Treatment of Schizophrenia—Selected Posters
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 3
SP 15
OP 16
DO 10.1177/155989770800800312
UL http://mdc.sagepub.com/content/8/3/15.2.abstract
AB The goals for the management of schizophrenia and schizoaffective disorders are to decrease severity and frequency of psychosis and associated mood symptoms while reducing the inherent risks of antipsychotic medications. Aripiprazole demonstrates agonist activity toward dopamine D2 and 5-HT1a receptors and antagonizes 5-HT2a receptors, sites that are associated with psychosis and mood disorders.